DexCom (DXCM) Misses Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $84.53 -3.83%
EPS Growth %: +9.8%
Financial Fact:
Total revenue: 148.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.8%
Financial Fact:
Total revenue: 148.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.07), $0.06 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $105.2 million versus the consensus estimate of $99.88 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- CBRE Global Real Estate Income Fund adjusts September distribution after split
- BMO Capital Starts Carter's (CRI) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
